Finland· FI-REL-REL59259
Ritonavir Viatris
A ritonavir product containing ritonavir, registered in Finland by Orifarm Oy. The same ATC class is registered in 16 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ritonavir is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AE03 (ritonavir), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Ritonavir · ATC J05AE03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ritonavir costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), the median price runs from $4.15 in France to $20.09 in Switzerland — a ×4.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ritonavir · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$20.09
- FR France$4.15
The record
At a glance
Fimea (Finland)- Active substance
- Ritonavir
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- J05AE03
- ATC class
- Ritonavir
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
515 interactions on record for ritonavir.
Graded by severity as the source publishes them — 149 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ritonavir · interactions on record
515 records
- 149 severe
- 238 moderate
- 19 minor
- 66 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- EluxadolineA07DA06severe
43 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ritonavir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNORVIRAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- United StatesNorvirAbbVie Inc.
- BelgiumKaletra 100 mg - 25 mgAbbVie Deutschland
- NetherlandsNorvir 100 mg, filmomhulde tabletAbbVie Deutschland GmbH & Co. KG
- PolandNorvirAbbVie Deutschland GmbH & Co. KG
- SwedenNorvir 100 mg Filmdragerad tablettAbbVie Deutschland GmbH & Co KG
- FranceNORVIR 100 mg, comprimé pelliculéABBVIE DEUTSCHLAND (ALLEMAGNE)
- SpainNORVIR 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAbbvie Deutschland Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Ritonavir Accord
- Belgium · Ritonavir Accord
- Cyprus · Ritonavir Accord
- Germany · Ritonavir Accord, Ritonavir Hexal
- Denmark · Ritonavir Accord
- Estonia · Ritonavir Auxilia
- Spain · Ritonavir Accord
- France · Ritonavir Arrow
- United Kingdom (Northern Ireland) · Norvir, Ritonavir Accord Healthcare
- Hungary · Ritonavir Accord
- Iceland · Norvir, Ritonavir Viatris
- Italy · Ritonavir Sandoz
- Liechtenstein · Norvir, Ritonavir Viatris
- Netherlands · Ritonavir Accord, Ritonavir Sandoz
- Norway · Norvir, Ritonavir Viatris
- Poland · Ritonavir Accord, Ritonavir Aurovitas
- Portugal · Ritonavir Farmoz, Ritonavir Generis
- Sweden · Ritonavir Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b07eb3af-afbf-44e2-a78e-8204ee2bc126 GET /v1/drugs/b07eb3af-afbf-44e2-a78e-8204ee2bc126?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1.2",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "100 mg",
"atc_label": "ritonaviiri",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/17/1242/001",
"fimea_rel_id": "REL59259",
"authorised_at": "2021-10-12"
}See everything about ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.